Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.
2.

Clinical safety of tazarotene in the treatment of plaque psoriasis.

Marks R.

J Am Acad Dermatol. 1997 Aug;37(2 Pt 3):S25-32. Review.

PMID:
9270553
3.

Efficacy and safety of topical tazarotene: a review.

Talpur R, Cox K, Duvic M.

Expert Opin Drug Metab Toxicol. 2009 Feb;5(2):195-210. Review.

PMID:
20213916
4.

Tazarotene gel: efficacy and safety in plaque psoriasis.

Weinstein GD.

J Am Acad Dermatol. 1997 Aug;37(2 Pt 3):S33-8. Review.

PMID:
9270554
5.

Pharmacokinetics and safety review of tazarotene.

Marks R.

J Am Acad Dermatol. 1998 Oct;39(4 Pt 2):S134-8. Review.

PMID:
9777791
6.

The efficacy of topical tazarotene monotherapy and combination therapies in psoriasis.

Koo J, Behnam SE, Behnam SM.

Expert Opin Pharmacother. 2003 Dec;4(12):2347-54. Review.

PMID:
14640932
7.

Clinical efficacy and safety of tazarotene: optimizing clinical results.

Lebwohl M.

Cutis. 1998 Feb;61(2 Suppl):27-9. Review.

PMID:
9787989
8.

The role of tazarotene in the treatment of psoriasis.

Marks R.

Br J Dermatol. 1999 Apr;140 Suppl 54:24-8. Review.

PMID:
10731131
10.

Adverse reactions to cosmetics and methods of testing.

Nigam PK.

Indian J Dermatol Venereol Leprol. 2009 Jan-Feb;75(1):10-8; quiz 19. Review.

11.

A systematic review of adverse effects associated with topical treatments for psoriasis.

Bruner CR, Feldman SR, Ventrapragada M, Fleischer AB Jr.

Dermatol Online J. 2003 Feb;9(1):2. Review.

PMID:
12639460

Supplemental Content

Support Center